Geode Capital Management, LLC Global Blood Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$32.4 - $68.18 $1.9 Million - $4 Million	58,608 Added 5.41%	1,142,444 $77.8 Million
Q2 2022 Aug 12, 2022	SELL	$22.3 - $37.39 $62,172 - $104,243	-2,788 Reduced 0.26%	1,083,836 $34.6 Million
Q1 2022 May 13, 2022	BUY	$25.68 - $35.59 $323,285 - $448,042	12,589 Added 1.17%	1,086,624 $37.6 Million
Q4 2021 Feb 11, 2022	BUY	$24.9 - $40.26 $284,607 - $460,171	11,430 Added 1.08%	1,074,035 $31.4 Million
Q3 2021 Nov 12, 2021	SELL	$25.48 - $37.34 $1.03 Million - $1.51 Million	-40,358 Reduced 3.66%	1,062,605 $27.1 Million
Q2 2021 Aug 13, 2021	BUY	$32.46 - $43.42 $10.8 Million - $14.5 Million	333,240 Added 43.29%	1,102,963 $38.6 Million
Q1 2021 May 12, 2021	BUY	$38.94 - $50.85 $700,647 - $914,944	17,993 Added 2.39%	769,723 $31.4 Million
Q4 2020 Feb 12, 2021	BUY	$37.65 - $63.77 $2.36 Million - $4 Million	62,765 Added 9.11%	751,730 $32.6 Million
Q3 2020 Nov 13, 2020	SELL	$52.76 - $74.49 $1.43 Million - $2.02 Million	-27,069 Reduced 3.78%	688,965 $38 Million
Q2 2020 Aug 13, 2020	SELL	$48.73 - $81.82 $8.13 Million - $13.6 Million	-166,769 Reduced 18.89%	716,034 $45.2 Million
Q1 2020 May 14, 2020	BUY	$41.72 - $87.2 $2.56 Million - $5.36 Million	61,459 Added 7.48%	882,803 $45.1 Million
Q4 2019 Feb 13, 2020	BUY	$45.7 - $81.86 $1.13 Million - $2.03 Million	24,775 Added 3.11%	821,344 $65.3 Million
Q3 2019 Nov 12, 2019	BUY	$45.35 - $57.91 $2.89 Million - $3.69 Million	63,646 Added 8.68%	796,569 $38.6 Million
Q2 2019 Aug 14, 2019	BUY	$52.6 - $63.29 $2.9 Million - $3.5 Million	55,226 Added 8.15%	732,923 $38.6 Million
Q1 2019 May 14, 2019	BUY	$39.99 - $53.48 $2.32 Million - $3.1 Million	57,967 Added 9.35%	677,697 $35.9 Million
Q4 2018 Feb 13, 2019	BUY	$31.54 - $46.67 $2.63 Million - $3.89 Million	83,347 Added 15.54%	619,730 $25.4 Million
Q3 2018 Nov 13, 2018	BUY	$38.0 - $51.1 $1.15 Million - $1.55 Million	30,238 Added 5.97%	536,383 $20.4 Million
Q2 2018 Aug 14, 2018	BUY	$38.7 - $50.15 $3.34 Million - $4.33 Million	86,358 Added 20.57%	506,145 $22.9 Million
Q1 2018 May 15, 2018	BUY	$39.6 - $65.9 $3.12 Million - $5.2 Million	78,836 Added 23.12%	419,787 $20.3 Million
Q4 2017 Feb 13, 2018	BUY	$29.7 - $45.7 $233,887 - $359,887	7,875 Added 2.36%	340,951 $13.4 Million
Q3 2017 Nov 14, 2017	BUY	$25.1 - $31.05 $1.15 Million - $1.42 Million	45,681 Added 15.89%	333,076 $10.3 Million
Q2 2017 Aug 14, 2017	BUY	N/A	287,395	287,395 $7.86 Million

Others Institutions Holding GBT

# of Institutions

Shares Held

288K

Call Options Held

Put Options Held

View Full List

About Global Blood Therapeutics, Inc.

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

More about GBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account